[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$ftMgcnwsLI9zH8T1U0HZgwWTzX46EZWjDhq0iTp2AK-Q":8,"$fE3m2qCetH9jagriDMcRZzUwoD8MkwqbsHefiDD1MoGA":55,"$frzxulq4gn5oFd7MJeCHMvBoRwYAKbvMMmCFqy3z1wIo":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},52321,867211,[],"https://ystcdn.venuertc.com/medical/ystApp/FRfzTr7rRcZ9NIepJ9KtSQ9JF0EHCJzK.png","赵念初","新乐市中医医院","肿瘤科","住院医师",186,0,"乳腺癌II期浸润性导管癌常用化疗与靶向用药实用全指南","","https://ystcdn.venuertc.com/venue/AI/bf16241e-1ff4-4f6f-8d32-f50e04e499ba.jpg","\u003Cdiv class=\"druguse-guide-main\">\n  \u003Ch1 id=\"material_title\" class=\"druguse-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌II期浸润性导管癌常用化疗与靶向用药实用全指南\u003C/h1>\n  \n  \u003Cdiv class=\"druguse-section\">\n    \u003Cdiv class=\"druguse-subtitle-bg\">\n      \u003Ch2 class=\"druguse-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01. 乳腺癌化疗与靶向治疗用药简介 ⚗️\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"druguse-content\">\n      \u003Cp>\n        说起来，化疗药物和靶向制剂是乳腺癌治疗中经常会遇到的两类药品。化疗药通常属于细胞毒类，比如紫杉类、蒽环类。靶向类药物则多见于抗HER2药物、激素受体抑制剂等。这些药品的使用各有特殊要求和注意事项，正确掌握细节才能保证药效并减少风险。接下来，我们将深入讲解化疗与靶向药物使用最容易忽视的七大要点，助您轻松提升安全性。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"druguse-section\">\n    \u003Cdiv class=\"druguse-subtitle-bg\">\n      \u003Ch2 class=\"druguse-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02. 主要药品类别、成分与剂型一览 🧬\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"druguse-content\">\n      \u003Cul class=\"druguse-list\">\n        \u003Cli>\n          \u003Cb>紫杉类（如紫杉醇、白蛋白结合型紫杉醇/TAXOL, NAB-PAC）\u003C/b>：为注射剂，常规采用静脉滴注方式。\u003C/li>\n        \u003Cli>\n          \u003Cb>蒽环类（如多柔比星、表柔比星/DOXORUBICIN, EPIRUBICIN）\u003C/b>：亦为注射剂型，通过静脉用药。\u003C/li>\n        \u003Cli>\n          \u003Cb>抗HER2靶向药（曲妥珠单抗/HERCEPTIN；帕妥珠单抗/PERJETA等）\u003C/b>：为静脉注射溶液，单独或联合化疗药物使用。\u003C/li>\n        \u003Cli>\n          \u003Cb>内分泌调节剂（如他莫昔芬/TAMOXIFEN，来曲唑/LETROZOLE等）\u003C/b>：多为口服片剂。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"druguse-highlight-tip\">正确做法：\u003C/span> 静脉药品需严格遵循专业医师和护士的操作流程，口服制剂则需依个人剂量定时服用，切勿自行随意增减用量。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"druguse-section\">\n    \u003Cdiv class=\"druguse-subtitle-bg\">\n      \u003Ch2 class=\"druguse-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03. 药物作用机制简介（不涉用法）🧪\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"druguse-content\">\n      \u003Cp>\n        不同药物的作用机制简要归纳如下：\n      \u003C/p>\n      \u003Cul class=\"druguse-list\">\n        \u003Cli>\n          \u003Cb>紫杉类\u003C/b>：通过抑制细胞微管蛋白的聚合，使细胞停滞于分裂过程中，阻止有害细胞增殖。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>蒽环类\u003C/b>：直接插入DNA双链，阻断DNA复制与修复，最终导致靶细胞死亡。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>抗HER2药物\u003C/b>：通过结合细胞表面HER2受体，中断信号传导，阻止有害细胞过度生长。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>内分泌抑制剂\u003C/b>：干扰体内雌激素生成或受体结合，减少有害细胞增殖信号。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        需要注意：上述是药理机制简述，具体药物服用和剂量务必遵守医嘱。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"druguse-section\">\n    \u003Cdiv class=\"druguse-subtitle-bg\">\n      \u003Ch2 class=\"druguse-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04. 用药时间和服用方法指南⏱️\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"druguse-content\">\n      \u003Cul class=\"druguse-list\">\n        \u003Cli>\n          \u003Cb>静脉化疗药物：\u003C/b> 需在医院或合格门诊，由专业医护使用输液泵或滴注装置给药。用药周期一般3周为一周期，但具体时间由方案确定。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>靶向制剂：\u003C/b> 静脉注射，通常需与化疗同天用药或分开给药，具体顺序需遵医嘱。有些靶向药需先行低剂量过敏试验。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>口服内分泌药：\u003C/b> 建议每天固定时段整片吞服，用200ml以上温水送服，避免与葡萄柚汁、牛奶一同服用。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"druguse-highlight-tip\">正确做法：\u003C/span> 严格按照方案安排，如忘记服药，不可随意补充，请联系医生确认后处理。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"druguse-section\">\n    \u003Cdiv class=\"druguse-subtitle-bg\">\n      \u003Ch2 class=\"druguse-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05. 剂型特殊性及用药技巧💊\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"druguse-content\">\n      \u003Cul class=\"druguse-list\">\n        \u003Cli>\n          \u003Cb>注射剂型：\u003C/b> 化疗药、靶向药注射需通过输液港或外周静脉，避免外渗损伤组织。输液港需保持清洁无菌，避免感染。\u003C/li>\n        \u003Cli>\n          \u003Cb>肠溶片、缓释片：\u003C/b> 如遇有肠溶、缓释、控释片剂型，请整片吞服，不可掰碎或嚼服，避免影响药物释放。\u003C/li>\n        \u003Cli>\n          \u003Cb>口服药和食物：\u003C/b> 不同品牌有时要求餐前/餐后服用，以说明书为准。如他莫昔芬/来曲唑建议在餐前半小时或餐后立即服用。\u003C/li>\n        \u003Cli>\n          \u003Cb>充分饮水：\u003C/b> 服药时至少饮水200ml，预防药物残留于食管造成刺激。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        有临床观察显示，部分患者未按要求整片吞服肠溶片，导致用药效果差或胃肠反应加重，因此，正确服药方式非常关键。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"druguse-section\">\n    \u003Cdiv class=\"druguse-subtitle-bg\">\n      \u003Ch2 class=\"druguse-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06. 药物相互作用警示⚠️\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"druguse-content\">\n      \u003Cul class=\"druguse-list\">\n        \u003Cli>\n          \u003Cb>与华法林等抗凝药：\u003C/b> 某些化疗及靶向药物可增强抗凝效果，增加出血风险，需密切监测凝血指标。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>与 CYP3A4 抑制剂：\u003C/b> （如大剂量葡萄柚汁、某些抗真菌药）可升高紫杉醇血药浓度，增强毒性。\u003C/li>\n        \u003Cli>\n          \u003Cb>与某些抗生素：\u003C/b> 氨基糖苷类和部分化疗药（如多柔比星）合用时，肾毒性和耳毒性可能加重。\u003C/li>\n        \u003Cli>\n          \u003Cb>大剂量维生素 C：\u003C/b> 有数据提示可能干扰部分化疗药代谢，但临床效果仍需更多证据。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"druguse-highlight-tip\">正确做法：\u003C/span> 开始任何新药、保健品或食物补充剂前，请提前咨询医生或药师。合用期间如发现异常反应，应及时停用并就诊。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"druguse-section\">\n    \u003Cdiv class=\"druguse-subtitle-bg\">\n      \u003Ch2 class=\"druguse-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07. 特殊人群及剂量调整须知👩‍🦳\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"druguse-content\">\n      \u003Cul class=\"druguse-list\">\n        \u003Cli>\n          \u003Cb>老年患者：\u003C/b> 药物代谢能力下降，部分药需酌情减量或延长给药间隔。实际用药应依据肝、肾功能。\u003C/li>\n        \u003Cli>\n          \u003Cb>肝功能减退：\u003C/b> 紫杉醇、蒽环类等主要经肝代谢，肝损者须调整剂量，必要时暂停。\u003C/li>\n        \u003Cli>\n          \u003Cb>肾功能异常：\u003C/b> 极少数药物以肾脏为主要排泄路径（如顺铂），应根据肾功调整剂量。\u003C/li>\n        \u003Cli>\n          \u003Cb>孕妇、哺乳期：\u003C/b> 多数化疗及靶向药禁止使用。特殊情况下必须用药时，需权衡利弊并避开哺乳期。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        正确做法：用药前告知医生全身健康状况与既往用药史，有疑问及时反馈。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"druguse-section\">\n    \u003Cdiv class=\"druguse-subtitle-bg\">\n      \u003Ch2 class=\"druguse-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08. 常见不良反应与安全管理建议🛡️\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"druguse-content\">\n      \u003Cul class=\"druguse-list\">\n        \u003Cli>\n          \u003Cb>胃肠反应：\u003C/b> 如恶心、呕吐、腹泻是化疗常见不适。按医师具体方案使用止吐药、补液，并适量进食清淡食物。\u003C/li>\n        \u003Cli>\n          \u003Cb>骨髓抑制：\u003C/b> 可能出现白细胞、红细胞或血小板减少，定期检测血常规是必须的措施。\u003C/li>\n        \u003Cli>\n          \u003Cb>脱发：\u003C/b> 部分化疗药物（如紫杉醇）引起脱发现象，一般为暂时性，用药结束后缓慢恢复。\u003C/li>\n        \u003Cli>\n          \u003Cb>过敏反应：\u003C/b> 尤其紫杉醇、靶向药可能出现过敏，首次注射需密切监测，必要时提前用抗过敏药物。\u003C/li>\n        \u003Cli>\n          \u003Cb>局部静脉炎及外渗：\u003C/b> 部分注射药易导致局部刺激，应由专业人士操作，发现红肿、疼痛及时报告。\u003C/li>\n        \u003Cli>\n          \u003Cb>肝肾毒性：\u003C/b> 蒽环类、紫杉类使用期间需监测肝肾功能，早期发现损伤。\u003C/li>\n      \u003C/ul>\n      \u003Cul class=\"druguse-case-list\">\n        \u003Cli>\n          \u003Cb>临床案例：\u003C/b> 有60岁女性静脉化疗期间出现药物相关腹泻，减低剂量后症状缓解。这提示剂量调整能显著改善耐受性。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>观察数据：\u003C/b> 研究显示，紫杉醇类药物的恶心发生率约50%，而严重过敏反应小于2%（Swain et al., 2013）。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        出现重度副作用如高热、持续呕吐、极度乏力、出血点等，务必及时就诊。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"druguse-section\">\n    \u003Cdiv class=\"druguse-subtitle-bg\">\n      \u003Ch2 class=\"druguse-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09. 药物储存与管理细节📦\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"druguse-content\">\n      \u003Cul class=\"druguse-list\">\n        \u003Cli>\n          \u003Cb>注射剂型药物：\u003C/b> 多为冷链储存（2-8℃）运输，开封后遵从说明书当日用完。部分冻干粉需避光。\u003C/li>\n        \u003Cli>\n          \u003Cb>口服药片/胶囊：\u003C/b> 封口密封，干燥阴凉避光处保存，室温不超过25℃。\u003C/li>\n        \u003Cli>\n          \u003Cb>液体剂型：\u003C/b> 有效期按包装标注，开启瓶盖后30日内最好用完。\u003C/li>\n        \u003Cli>\n          \u003Cb>过期药品：\u003C/b> 不再继续服用，交由医院专业回收点处理。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"druguse-highlight-tip\">提醒：\u003C/span> 请勿将药品随意放在冰箱冷冻层，也不可与食物混合存放。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"druguse-section\">\n    \u003Cdiv class=\"druguse-subtitle-bg\">\n      \u003Ch2 class=\"druguse-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10. 漏服/过量处理原则⌛\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"druguse-content\">\n      \u003Cul class=\"druguse-list\">\n        \u003Cli>\n          \u003Cb>口服药物：\u003C/b> 如忘记服用，假如距离下一次服药时间超过8小时，可立即补服；如接近下次服药时间，则跳过漏服，继续后续服用，不可双倍剂量补偿。\u003C/li>\n        \u003Cli>\n          \u003Cb>静脉注药：\u003C/b> 一旦漏用不宜自行补药，应与主治团队协商后依照医嘱调整排程。\u003C/li>\n        \u003Cli>\n          \u003Cb>过量服用：\u003C/b> 有明显不适须就医，对于强致吐、乏力、心跳异常等严重表现不可自行处理。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"druguse-highlight-tip\">特别提醒：\u003C/span> 过量用药危害极大，请立即就医并出示所用药物包装与说明。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"druguse-section\">\n    \u003Cdiv class=\"druguse-subtitle-bg\">\n      \u003Ch2 class=\"druguse-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11. 结语：用药安全最重要🌷\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"druguse-content\">\n      \u003Cp>\n        综合来看，无论化疗药还是靶向制剂，规范用药、定期检测、关注不良反应、专注冷链和储存细节，是保障用药安全最核心的环节。每一步看似平常，实际都关乎全局。不要忽视每个细微操作，遇到问题积极求助药师或主诊医生，安全用药，治疗才会从容顺利。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"druguse-section\">\n    \u003Cdiv class=\"druguse-subtitle-bg\">\n      \u003Ch2 class=\"druguse-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"druguse-content\">\n      \u003Col class=\"druguse-ref-list\">\n        \u003Cli>\n          NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Breast Cancer. Version 3.2022. National Comprehensive Cancer Network.\n        \u003C/li>\n        \u003Cli>\n          Swain, S. M., Baselga, J., Kim, S. B., et al. (2015). Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. New England Journal of Medicine, 372(8), 724-734.\n        \u003C/li>\n        \u003Cli>\n          Sparano, J. A., et al. (2018). Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. New England Journal of Medicine, 379(2), 111-121.\n        \u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n/* 全局样式，独立命名，避免影响嵌入页面 */\n.druguse-guide-main {\n  font-family: \"Segoe UI\", \"Helvetica Neue\", Arial, \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei\", sans-serif;\n  background: #f9fafb;\n  box-sizing: border-box;\n  margin: 0 auto;\n  padding: 32px 0 32px 0;\n  max-width: 850px;\n}\n.druguse-title {\n  color: #292965;\n  font-size: 2.4rem;\n  font-weight: 700;\n  letter-spacing: 1.5px;\n  margin: 0 32px 36px 32px;\n  padding-bottom: 14px;\n  border-bottom: 2px solid #e5e7f0;\n}\n.druguse-section {\n  background: #fff;\n  margin: 32px 24px;\n  border-radius: 14px;\n  box-shadow: 0 4px 18px 0 #ecedfa66;\n  overflow: hidden;\n}\n.druguse-subtitle-bg {\n  padding: 0;\n  margin: 0;\n  background: linear-gradient(90deg, #eef1f7 66%, #f7f0fc 100%);\n  border-bottom: 1.5px solid #e0e3ea;\n}\n.druguse-subtitle {\n  color: #2b277a;\n  font-size: 1.26rem;\n  letter-spacing: 1.2px;\n  font-weight: 600;\n  margin: 0;\n  padding: 18px 36px 12px 30px;\n  line-height: 1.5;\n}\n.druguse-content {\n  font-size: 1.06rem;\n  color: #243241;\n  padding: 24px 34px 26px 34px;\n  line-height: 2.1;\n  background: none;\n}\n.druguse-list {\n  margin: 0 0 0 0;\n  padding: 0 0 0 24px;\n  color: #44527a;\n}\n.druguse-list li {\n  margin-bottom: 12px;\n  padding-left: 0;\n}\n.druguse-highlight-tip {\n  background: #f5f8ff;\n  border-radius: 6px;\n  color: #23417c;\n  padding: 2px 10px;\n  margin-right: 3px;\n  font-weight: 600;\n}\n.druguse-case-list {\n  margin: 24px 0 0 0;\n  padding: 0 0 0 24px;\n  color: #257459;\n}\n.druguse-case-list li {\n  margin-bottom: 8px;\n}\n.druguse-ref-list {\n  margin: 10px 0 0 15px;\n  padding: 0 0 0 18px;\n  color: #23759a;\n  font-size: 1.02rem;\n  line-height: 1.85;\n}\n@media (max-width: 650px) {\n  .druguse-title { font-size: 1.24rem; padding-bottom: 6px; margin: 0 10px 16px 10px;}\n  .druguse-section { margin: 16px 2px;}\n  .druguse-subtitle { font-size: 1.08rem; padding: 12px 10px 8px 14px;}\n  .druguse-content { font-size: 0.99rem; padding: 12px 10px 10px 14px;}\n}\n\u003C/style>\n","\u003Cdiv class=\"druguse-guide-main\">\n  \u003Ch1 id=\"material_title\" class=\"druguse-title\" style=\"color: rgb(4",527,"2025-07-25 11:15:19","乳腺癌, 化疗, 靶向治疗, 药物使用, 不良反应","深入了解乳腺癌Ⅱ期浸润性导管癌的化疗与靶向治疗，掌握使用药物的最佳实践，降低不良反应，提高康复安全性，关注健康人士不可错过的信息。","2025-07-25 18:18:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]